Gambling.com Group Ltd - Common Stock, no par value (GAMB)

CUSIP: G3R239101

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class
Equity / Common Stock, no par value
Total 13F shares
12,158,413
Total 13F value
$118,533,634
Holder snapshot 6 visible 7 signals
Share change
+408,291
Put/Call ratio
1611%
SEC-reported price per share
$9.75
Number of holders
93
Value change
+$1,840,225
Number of buys
54
Open additional details 1 more signal available
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,020,803

Security key

G3R239101

Report period

Q4 2023

Institutions

93

Top holders

10

GAMB full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2024 Previous quarter: Q3 2023 Gambling.com Group Ltd SEC filings Gambling.com Group Ltd company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GAMB - Gambling.com Group Ltd - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
G2 Investment Partners Ma...
Disclosed value leader
G2 Investment Partners Ma...
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F Lead comparable stake: 4.8% Showing 1-6 of 15 holder rows.

Quick read

G2 Investment Partners Management LLC leads the comparable SEC ownership view at 4.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens G2 Investment Partners Management LLC's linked filing trail.
Comparable ownership Top 5
G2 Investment Partners Management... 4.8%
Stanley-Laman Group, Ltd. 3.8%
DRIEHAUS CAPITAL MANAGEMENT LLC 2.9%
BlackRock Finance, Inc. 2.1%
Clearbridge Investments, LLC 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
G2 Investment Partners Management LLC
13F
Company
13F
4.8%
$22,125,055
1,691,518 shares
 — 30 Sep 2023
Stanley-Laman Group, Ltd.
13F
Company
13F
3.8%
$17,588,323
1,344,673 shares
 — 30 Sep 2023
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
13F
2.9%
$13,102,982
1,001,757 shares
 — 30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
2.1%
$9,774,893
747,316 shares
 — 30 Sep 2023
Clearbridge Investments, LLC
13F
Company
13F
2.1%
$9,514,210
727,386 shares
 — 30 Sep 2023
Potrero Capital Research LLC
13F
Company
13F
1.6%
$7,322,799
559,847 shares
 — 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
93
Shares
12,158,413
Rows available
93
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
90
Q4 2023 holders
93
Holder diff
3
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .